Drug Type Antibody drug conjugate (ADC) |
Synonyms- |
Target |
Mechanism CDH17 antagonists(Cadherin-17 antagonists), Tubulin inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Arbele Corp.Startup |
Active Organization Arbele Ltd.Arbele Corp.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC11H22N4O4 |
InChIKeyAGGWFDNPHKLBBV-YUMQZZPRSA-N |
CAS Registry159858-33-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Gastrointestinal Neoplasms | Preclinical | HK | 22 Mar 2024 |